MD, Associate Chief Physician, Department of Interventional Therapy, Peking University Cancer Hospital. Specialties: Engaged in minimally invasive interventional therapy for malignant tumors and their complications. Has published numerous papers and monographs, and participated in multiple international and domestic multi‑center research projects. Examples include: Phase IV clinical study of Licartin combined with transarterial chemoembolization (TACE) against hepatocellular carcinoma recurrence and metastasis, a sub‑project under the National Major Science and Technology Project for "Prevention and Treatment of Major Infectious Diseases such as AIDS and Viral Hepatitis"; National Natural Science Foundation project "Establishment and clinical value evaluation of an efficacy evaluation model for hepatic artery infusion chemotherapy in advanced colorectal cancer with liver metastasis based on multimodal radiomics and artificial intelligence"; and the "Summit" Talent Training Program for Minimally Invasive Interventional Oncology of Beijing Hospital Management Center.
English